CCXI - Chemocentryx

[Mark P.]

After purchasing more shares of this biotech stock this week I am now in a position to share with the message board this stock that I like so much.  I came across this company several months ago by happen chance, and thus far it has been a real winner with lots of room to run.

One reason I like this stock includes the deep pipeline of drugs that appear to have a bright future.  Take a look at some recent SEC filings and you will find that they have 5 or 6 products that appear posed to be real winners.  They also recently signed a licenses marketing agreement on just one of their promising drugs (CCX168).  The monetary compensation of this deal is $85MM upfront with total potential compensation up to $600MM. Up until this agreement was signed the market cap was just above $100MM, and had decreased significantly over the last year or two. Since this agreement occurred the stock has more than doubled.

I first bought this this stock back in early April, and have purchased it several times since then.  To conclude I like the biotech industry because of the large amount of cash companies have on hand, and the potential to earn an outstanding return on my money.  With research of the SEC filings I feel like you can sift through the winners and losers, but it does take time and lots of research.

http://finance.yahoo.com/q?s=CCXI

http://www.streetinsider.com/Corporate+News/Vifor+Pharma+Licenses+Marketing+Rights+to+ChemoCentryxs+(CCXI)+CCX168/11608024.html


Mark P.

[Mark P.]

http://www.chemocentryx.com/

[Dexter]

Interesting idea -- thanks for sharing.  I'll have to dig into this company a little bit.

What do you think CCXI is worth?

[Mark P.]

Personally I think this company will grow or get bought at over $2B - $3B at some point in the next 5-7 years.  Their pipeline is very strong and I think you will see more licensing agreements like the Vifor one in the near future.

Mark P.

[Dexter]

CCXI stock took a 20% dive today. 

Is this a reaction to the initial results announced by the company regarding the Ongoing Phase Ib Clinical Trial of CCX872 in Patients with Advanced Pancreatic Cancer?

http://finance.yahoo.com/news/chemocentryx-reports-initial-results-ongoing-200500827.html

Mark P., what are your thoughts?

[Mark P.]

Yes, pancreatic cancer is a tough one to crack and I was definetly the cause of CCXI to take a dive in the market.  However, I think with their deep pipeline of other drugs and the progression they are getting with those, this stock will take off in the next year or two.  I think since you last posted it has come up almost to the level it was before the 20% drop-off.  Here's to hoping for a bright future for CCXI.  By the way I still think there is a lot of upside for this company and could be an interesting buy at $5/share or below.

Thanks,

Mark P.

[Dexter]

I hadn't even noticed that the stock had basically climbed back to where it was before the drop.

Is there one drug in particular that you think could be a blockbuster?  Or do you think most of the drugs in their pipeline have a strong chance of doing well?

[Mark P.]

Yes they recently came up beyond their 20% drop and continues to grow.  I think this article does a good job of explaining why this stock had its recent uptick.  http://www.insidermonkey.com/blog/healthcare-focused-michael-castor-added-these-stocks-to-his-portfolio-last-quarter-475621/?yptr=yahoo

To answer your other question, off the top of my head I don't know the specific drug that I like the most in their pipeline but rather I think the company as a whole has several drugs with a really good potential of doing what they are supposed to.

As always this is a volatile industry and anything can happen, however, I think this stock has a real good opportunity to make it big.

Mark P.

[Dexter]

Two good pieces of news for ChemoCentryx:

http://finance.yahoo.com/news/chemocentryx-announces-presentation-positive-data-123000833.html

http://finance.yahoo.com/news/chemocentryx-ccr2-inhibitor-ccx872-shown-123000745.html